MARKET

MEDP

MEDP

Medpace Holdings
NASDAQ
544.77
-31.72
-5.50%
Pre Market: 545.00 +0.23 +0.04% 07:24 12/05 EST
OPEN
574.09
PREV CLOSE
576.49
HIGH
576.29
LOW
530.96
VOLUME
71
TURNOVER
0
52 WEEK HIGH
626.26
52 WEEK LOW
250.05
MARKET CAP
15.35B
P/E (TTM)
38.10
1D
5D
1M
3M
1Y
5Y
1D
Jefferies says market thinking ‘backwards’ on FDA one trial proposal
TipRanks · 1h ago
Here's Why You Should Add Inogen Stock to Your Portfolio Now
NASDAQ · 3h ago
Medpace CEO Makes a Strategic Move with Stock Sale
TipRanks · 14h ago
Medpace CEO August J. Troendle Reports Sale of Common Shares
Reuters · 19h ago
CROs fall as FDA head Makary says drug approvals will require fewer trials
Seeking Alpha · 22h ago
GEHC and Mayo Clinic Launch GEMINI-RT to Aid Personalized Cancer Care
NASDAQ · 1d ago
FDA shift in drug study requirements sends trial runners lower
TipRanks · 1d ago
FDA to reduce number of trials required for drug approvals, STAT reports
TipRanks · 1d ago
More
About MEDP
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company’s drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company’s operations are principally based in North America, Europe, and Asia.

Webull offers Medpace Holdings Inc stock information, including NASDAQ: MEDP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MEDP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MEDP stock methods without spending real money on the virtual paper trading platform.